Visual analysis of the treatment of non-alcoholic fatty liver disease based on Web of Science
- VernacularTitle:基于WebofScience的非酒精性脂肪肝病治疗研究可视化分析
- Author:
Baoqiang ZHU
1
,
2
;
Mingming ZHANG
3
;
Shiyu YANG
3
;
Jiaqiang HU
3
;
Wenyuan LI
2
;
Enwu LONG
1
Author Information
1. School of Pharmacy，Southwest Medical University，Sichuan Luzhou 646000，China
2. Department of Pharmacy，Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital/Affiliated Hospital of University of Electronic Science and Technology of China，Chengdu 610072，China
3. School of Medicine，University of Electronic Science and Technology of China，Chengdu 610054，China
- Publication Type:Journal Article
- Keywords:
non-alcoholic fatty liver disease;
therapy;
CiteSpace;
Web of Science;
visual analysis
- From:
China Pharmacy
2023;34(18):2243-2249
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To analyze the current status， hotspots and development trends of research on the treatment of non-alcoholic fatty liver disease （NAFLD）， providing reference for subsequent research. METHODS Searching the Web of Science database， the literature related to the treatment of NAFLD from the establishment of the database to December 31， 2022 were collected. CiteSpace 6.1.R6 was used to construct a visual atlas， perform collaborative network analysis on authors， countries and institutions， and conduct keyword co-occurrence， clustering and emergence analysis to explore its research status and hotspots. RESULTS A total of 3 882 articles were included， and the number of publications had been increasing year by year. The top three countries in terms of publication volume were China， the United States， and Japan. The author with the highest volume of publications was Sanyal from the United States （37 articles）， while the institution with the highest volume of publications was the University of California， San Diego （75 articles）. A closely connected research team abroad mainly conducted large-scale randomized controlled trials （RCT） to evaluate the effectiveness and safety of various interventions， including medication and lifestyle， in treating NAFLD. However， domestic researches mainly focused on basic researches about the treatment of NAFLD with effective medicinal ingredients， and were characterized by traditional Chinese medicine. There were relatively few high-quality large-scale RCT studies related to it. Keyword analysis showed that researches in various countries mainly focused on regulating liver oxidative stress and inflammation， improving the overall balance of glucose and lipid metabolism. Except for hypoglycemic drugs， drugs that act on various comprehensive metabolic homeostasis targets in the body had entered clinical research， and had enormous therapeutic potential. CONCLUSIONS The research on NAFLD treatment continues to grow in popularity and tends to research targets and drugs for regulating systemic metabolic homeostasis. As the main force of research， China should strengthen communication with the international community， grasp the trends and directions of basic research， attach importance to clinical research， and continuously tap the therapeutic potential of traditional Chinese medicine.
